Arun Sanyal
Dr. Arun Sanyal is a prominent hepatologist and the director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. He is recognized for his extensive research in liver diseases, particularly metabolic liver disorders such as metabolic dysfunction associated steatohepatitis (MASH). Recently, he gained attention for his role in a groundbreaking clinical trial that demonstrated the effectiveness of semaglutide injections in reversing severe liver disease, providing new hope for patients suffering from fatty liver disease.
Not in the pool (under ¢1).
Recent news mentions
Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants.
Hidden dangers of common medications and supplements causing liver damage
United States· 2025-06-02
Arun Sanyal from Virginia Commonwealth University was one of the principal researchers in the trial of semaglutide.
دواء شهير للسكري والسمنة يعالج مرض الكبد الدهني بفعالية
Saudi Arabia· 2025-05-03
Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants.
Severe liver disease reversed with semaglutide injections, study revealsUnited States· 2025-05-03
